Ingrid Teige Selected Research

Rituximab (Mabthera)

11/2022

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Teige Research Topics

Disease

10	Neoplasms (Cancer) 11/2022 - 04/2013
6	Inflammation (Inflammations) 01/2010 - 05/2003
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2010 - 08/2008
2	Multiple Myeloma 06/2015 - 04/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022
1	Vaccinia 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2018
1	Smoldering Multiple Myeloma 01/2017
1	Disease Progression 06/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2010
1	Hyperplasia 08/2008
1	Rheumatoid Arthritis 12/2005
1	Experimental Arthritis 12/2005
1	Synovitis 03/2005
1	Eosinophilia 03/2005

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 01/2021 - 04/2015
4	CytokinesIBA 01/2010 - 05/2003
2	AntigensIBA 01/2022 - 11/2018
2	EpitopesIBA 12/2020 - 04/2013
2	IgG Receptors (Fc gamma RI)IBA 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2017 - 06/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009 - 08/2008
2	Keratin-14 (Keratin 14)IBA 06/2009 - 08/2008
1	Rituximab (Mabthera)FDA Link 11/2022
1	venetoclaxIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2018
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2018
1	tremelimumabIBA 01/2018
1	IpilimumabIBA 01/2018
1	Cell Surface ReceptorsIBA 04/2013
1	AutoantigensIBA 05/2010
1	Myelin Basic ProteinIBA 05/2010
1	IntegrinsIBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2008
1	Interleukin-22 (IL-22)IBA 08/2008
1	Interleukin-17 (Interleukin 17)IBA 08/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008
1	Interleukin-12 (IL 12)IBA 08/2008
1	Interferon-betaIBA 12/2005
1	CPG-oligonucleotideIBA 03/2005
1	Immunoglobulin E (IgE)IBA 03/2005

Therapy/Procedure

7	Therapeutics 11/2022 - 03/2005
2	Immunotherapy 11/2022 - 01/2019